Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of KL130008 in severe alopecia areata
CTR20221881Phase 2Terminated
- Sponsor
- Sichuan Kelun-Biotech Biopharmaceutical
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of KL130008 in alopecia areata, sponsored by Sichuan Kelun-Biotech Biopharmaceutical. Started Nov 2022; status: terminated.
02
Drugs
KL130008
03
Conditions
alopecia areata
Beyond the preview
Go deeper on CTR20221881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221881.